References
- Chapter 797 pharmaceutical compounding—sterile preparations. In: United States Pharmacopeia, 27th rev. National Formulary, 22nd ed. Rockville, MD: United States Pharmacopeial Convention; 2004.
- NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. DHHS (NIOSH) Publication No. 2004-165 (2004). Available online at: www.cdc.gov/niosh/docs/2004-165. Accessed July 25, 2006.
- Proposed revision to general chapter 797. Available online at: www.usp.org/USPNF/pf/797comments.html. Accessed July 25, 2006.
- USP 797 guidebook to proposed revisions pharmaceutical compounding-sterile preparations. Rockville, MD: United States Pharmacopeial Convention; 2006.
- Clarification: Expectations related to USP-NF Chapter 797 on compounding sterile preparations. Joint Commission Perspectives. April 2006;26:5–5(1).
- Midcalf B et al. (eds.) Pharmaceutical isolators: a guide to their application, design and control. London: Pharmaceutical Press, 2004.
- Valanis B, Vollmer WM, Steele P. Occupational exposure to antineoplastic agents: Self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med. 1999;41:632–8.
- Institute for Applied Healthcare Sciences for the German Society of Oncology Pharmacy. Quality standard for the pharmacy oncology service. [as a result of the] 11th German Conference for Oncology Pharmacy Services, January 2003.